Source: DGNews | Posted 9 years ago
Lamotrigine Dosing and Titration in Bipolar Trials Key to Prevention of Rash
Tags:
By Bruce Sylvester
Special to DG News
BARCELONA, SPAIN -- October 9, 2002 -- A review of 11 controlled bipolar and unipolar clinical trials indicates that, at recommended dosing levels, lamotrigine therapy is associated with no statistically or clinically higher rate of serious rash than placebo.
The studies, all between three and 78 weeks
Comments